Interestingly, the aggressive claudin-low subtype of triple-negative breast cancers showed high expression of HAS2, CD44 and ZEB1 (Figure 2H and Supplementary Figure S4D). The gene discussed is HAS2; the disease is triple-negative breast carcinoma.